As an offshoot of Fondazione Biotecnopolo di Siena, the «Centro nazionale anti pandemico-CNAP» focuses on the development and production of vaccines and monoclonal antibodies for the treatment of emerging epidemic and pandemic diseases.
For these activities, the Fondazione Biotecnopolo will make use of first- and second-level spoke centers, as well as pathogen sequencing networks, ensuring the necessary interactions with centers involved in the development of vaccines according to the One Health model.
The «Centro nazionale anti pandemico» (CNAP – National Pandemic Center) performs its functions within the initiatives of the «Innovative Health Ecosystem» intervention of the National Plan for Investments complementary to the National Recovery and Resilience Plan (NRRP).
The national preparedness activity of the CNAP aims to
The national
preparedness
activity of the
CNAP aims to
 |
Investigating, mapping and reducing the risk of emerging infectious diseases; |
|
Mitigating, preventing and detecting potential outbreaks; |
|
Monitoring, in the presence of epidemic emergencies, the degree and impact that the health crisis causes in different sectors, including non-health sectors; |
|
Maintaining and encouraging multidisciplinary and interdisciplinary research activities toward particular pathogens with epidemic and pandemic potential; |
|
Encouraging the implementation of programs for research, innovation and technology transfer to the production system in the field of biotechnology applications aimed at human health protection; |
|
Encouraging research on solutions to antibiotic resistance; |
|
Developing and producing pilot batches for emergency use; |
|
Ensuring liaisons with government agencies responsible for national and foreign security. |
|
Investigating, mapping and reducing the risk of emerging infectious diseases; |
|
Monitoring, in the presence of epidemic emergencies, the degree and impact that the health crisis causes in different sectors, including non-health sectors; |
|
Mitigating, preventing and detecting potential outbreaks; |
|
Maintaining and encouraging multidisciplinary and interdisciplinary research activities toward particular pathogens with epidemic and pandemic potential; |
|
Encouraging the implementation of programs for research, innovation and technology transfer to the production system in the field of biotechnology applications aimed at human health protection; |
|
Encouraging research on solutions to antibiotic resistance; |
|
Developing and producing pilot batches for emergency use; |
|
Ensuring liaisons with government agencies responsible for national and foreign security. |